Literature DB >> 7216421

Genetic control of susceptibility to Cryptococcus neoformans in mice.

J C Rhodes, L S Wicker, W J Urba.   

Abstract

Inbred mice injected intravenously with 5 x 10(6) cells of Cryptococcus neoformans showed two patterns of survival: sensitive (A/WySn, A.BY, A/J, DBA/2J, NZB/B1NJ, and SWR/J) and resistant [C57BL/10Sn, B10.A, B10.A (2R), B10.S (7R),C57BR/cdJ, C58/J, C3H/HeJ, BALB/c, DBA/1J, and SJL/J]. Relative susceptibility based on survival time was shown to correspond to differences obtained for 50% lethal dose values. Either decreasing the dose of organisms or changing to the intraperitoneal route of inoculation resulted in prolonged survival times, but neither change affected the observed patterns of survival. F1 hybrids between different sensitive strains were also sensitive, whereas F1 hybrids between sensitive and resistant strains were resistant, indicating a dominant mode of inheritance. Sensitivity and resistance were shown to be under single gene control by segregation analysis in F2 progeny produced by inbreeding (B10.A x A/WySn)F1 hybrids and in (F1 x A/WySn) backcross progeny. Blood obtained from parental strains, F1, F2, and backcross hybrids was tested for the presence or absence of hemolytic complement. Mice lacking hemolytic complement activity in their sera are homozygous for the Hc(0) allele at the Hc locus on chromosome 2 and are deficient in the complement component C5. A 1:1 correspondence was found between C5 deficiency and sensitivity to C. neoformans. Resistance was shown to cosegregate with the presence of hemolytic complement in the F2 and the backcross progenies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216421      PMCID: PMC551145          DOI: 10.1128/iai.29.2.494-499.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  THE INHERITANCE OF HEMOLYTIC COMPLEMENT ACTIVITY IN CF-1 MICE.

Authors:  D K TACHIBANA; M ULRICH; L T ROSENBERG
Journal:  J Immunol       Date:  1963-08       Impact factor: 5.422

2.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

3.  Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse.

Authors:  D J Bradley; B A Taylor; J Blackwell; E P Evans; J Freeman
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

4.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

5.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

6.  Medium for selective isolation of Cryptococcus neoformans.

Authors:  A B Shields; L Ajello
Journal:  Science       Date:  1966-01-14       Impact factor: 47.728

7.  Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred.

Authors:  R Snyderman; D T Durack; G A McCarty; F E Ward; L Meadows
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

8.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

9.  The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri.

Authors:  L D Caren; L T Rosenberg
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  60 in total

1.  Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice.

Authors:  Zewei Jiang; Ruth A Bryan; Alfred Morgenstern; Frank Bruchertseifer; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells.

Authors:  Ruth A Bryan; Zewei Jiang; Xianchun Huang; Alfred Morgenstern; Frank Bruchertseifer; Rani Sellers; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

Review 4.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

5.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Authors:  Alaka Mullick; Miria Elias; Serge Picard; Lucie Bourget; Orce Jovcevski; Susan Gauthier; Ashleigh Tuite; Penelope Harakidas; Craig Bihun; Bernard Massie; Philippe Gros
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Resistance to Paracoccidioides brasiliensis in mice is controlled by a single dominant autosomal gene.

Authors:  V L Calich; E Burger; S S Kashino; R A Fazioli; L M Singer-Vermes
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis.

Authors:  V L Calich; L M Singer-Vermes; A M Siqueira; E Burger
Journal:  Br J Exp Pathol       Date:  1985-10

9.  Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection.

Authors:  Ekaterina Dadachova; Antonio Nakouzi; Ruth A Bryan; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

10.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.